Indeed, higher levels of uric acid and hypoxanthine in samples from cancer patients, compared to controls were expected since cancer is associated with a rise in cellular turnover rate (Ridi and Tallima 2017) and xanthine oxidoreductase, which converts hypoxanthine to xanthine, is downregulated in cancer (Linder et al. 2005). Here, XDH is linked to cancer.